Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study

Table 2 Treatment and outcome of children with KD

Group	NKD	NNKD	P value
IVIG treatment duration (days)	7(6–8)	6(6–7)	0.002
IVIG dosage			0.009
2d/kg*1d	77(14.3%)	462(85.7%)
1 g/kg*2d	43(22.4%)	149(77.6%)
dipyridamole	39(37.5%)	224(33.3%)	0.404
CAL after treatment^a	58(31.9%)	250(22.8%)	0.008
CAA after treatment	4(6.9%)	26(10.4%)	0.418
IVIG nonresponders	5(3.0%)	51(5.8%)	0.167
Gender			0.715
Female	63(32.0%)	389(33.3%)
Male	134(68.0%)	779(66.7%)

^aCAL after treatment is defined as patients with persistent CAL after IVIG treatment. Values are expressed as Median (interquartile range) / Number (percentage). Continuous variables were compared using Kruskal-Wallis test, categorical variables were compared using Chi-square test

ISSN: 1471-2431